Sartorius AG Share Price
Stocks
SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Xetra
16:35:18 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 251.60 EUR | +0.08% |
|
-2.59% | +1.78% |
| 10-01 | Sartorius AG : Goldman Sachs sticks Neutral | ZD |
| 09-30 | Sartorius AG : Barclays remains its Buy rating | ZD |
| Market Cap | 15.67B 17.57B 14.6B 13.29B 25.02B 1,692B 25.21B 176B 68.64B 864B 65.95B 64.53B 2,776B | P/E 2026 * |
66.4x | P/E 2027 * | 50.9x |
|---|---|---|---|---|---|
| Enterprise Value | 19.25B 21.58B 17.93B 16.32B 30.73B 2,078B 30.96B 217B 84.3B 1,061B 80.99B 79.25B 3,409B | EV / Sales 2026 * |
5.17x | EV / Sales 2027 * | 4.64x |
| Free-Float |
35.87% | Yield 2026 * |
0.32% | Yield 2027 * | 0.39% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
OTC Markets
| SUVPF | Delayed | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
London S.E.
| 0NIR | Delayed | |
|
CBOE
| 0NIR | Real-time | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +0.08% | ||
| 1 week | -2.59% | ||
| Current month | -3.01% | ||
| 1 month | +6.07% | ||
| 3 months | +11.03% | ||
| 6 months | +18.46% | ||
| Current year | +1.78% |
| 1 week | 246.5 |  | 268.7 |
| 1 month | 226.2 | | 270 |
| Current year | 198.5 | | 270 |
| 1 year | 198.5 | | 270 |
| 3 years | 166.05 | | 383.7 |
| 5 years | 166.05 | | 631.6 |
| 10 years | 63.65 | | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 29/06/2025 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 31/03/2024 |
Volker Niebel
COO | Chief Operating Officer | 70 | 31/12/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 31/08/2002 |
Lothar Kappich
CHM | Chairman | 69 | 18/07/2017 |
| Director/Board Member | 77 | 28/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/05/26 | Free | Executive/Senior Manager | 4,268 | 0.0114% | ||
| 01/05/26 | Free | Executive/Senior Manager | 5,203 | 0.0139% | ||
| 12/03/26 | Buy | Chairman | 191 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.08% | -2.59% | +9.87% | -19.92% | 17.65B | |
| +3.35% | -0.27% | +24.56% | +35.89% | 242B | |
| +3.34% | -2.69% | +2.89% | +2.00% | 150B | |
| +3.71% | -2.00% | -10.14% | +40.12% | 138B | |
| -0.47% | -3.88% | -56.43% | -17.96% | 61.74B | |
| +2.44% | +0.46% | +13.18% | +20.82% | 49.08B | |
| -1.08% | -0.90% | -21.39% | -22.66% | 47.43B | |
| +2.09% | -2.24% | +20.93% | +55.22% | 47.3B | |
| +3.70% | +1.25% | -4.33% | +40.74% | 44.25B | |
| +3.51% | -0.64% | +34.02% | +65.46% | 41.78B | |
| Average | +2.07% | -2.67% | +1.32% | +19.97% | 84.03B | |
| Weighted average by Cap. | +2.71% | -3.02% | +4.19% | +24.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72B 4.17B 3.47B 3.16B 5.94B 402B 5.99B 41.91B 16.3B 205B 15.67B 15.33B 659B | 4.09B 4.58B 3.81B 3.46B 6.52B 441B 6.57B 46B 17.9B 225B 17.2B 16.83B 724B |
| Net income | 255M 286M 238M 216M 408M 27.56B 411M 2.87B 1.12B 14.07B 1.07B 1.05B 45.21B | 329M 369M 307M 279M 526M 35.55B 530M 3.71B 1.44B 18.15B 1.39B 1.36B 58.33B |
| Net Debt | 3.58B 4.01B 3.33B 3.03B 5.71B 386B 5.75B 40.25B 15.66B 197B 15.04B 14.72B 633B | 3.27B 3.67B 3.05B 2.77B 5.22B 353B 5.26B 36.81B 14.32B 180B 13.76B 13.46B 579B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | €251.60 | +0.08% | 84,334 |
| 02/10/26 | €251.40 | +0.16% | 103,977 |
| 01/10/26 | €251.00 | -3.24% | 82,247 |
| 30/09/26 | €259.40 | -0.23% | 143,697 |
| 29/09/26 | €260.00 | -1.33% | 67,052 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
